23andMe offers at-home test for breast cancer gene mutations

The DNA testing company 23andMe has gotten FDA approval to screen for 3 BRCA gene mutations linked to a higher risk of breast cancer. But the test raises some concerns. CBS San Francisco's Katie Nielsen reports.